🩺🚨 𝘓𝘪𝘱𝘰𝘱𝘳𝘰𝘵𝘦𝘪𝘯𝘢 𝘈 🚨

𝘜𝘯 𝘵𝘪𝘱𝘰 𝘥𝘪 𝘤𝘰𝘭𝘦𝘴𝘵𝘦𝘳𝘰𝘭𝘰 “𝘴𝘶𝘱𝘦𝘳 𝘤𝘢𝘵𝘵𝘪𝘷𝘰” 𝘦 𝘪𝘯𝘷𝘪𝘴𝘪𝘣𝘪𝘭𝘦, 𝘤𝘩𝘦 𝘰𝘱𝘦𝘳𝘢 𝘪𝘯𝘥𝘪𝘴𝘵𝘶𝘳𝘣𝘢𝘵𝘰 𝘦, 𝘴𝘱𝘦𝘴𝘴𝘰, 𝘷𝘪𝘦𝘯𝘦 𝘵𝘳𝘢𝘴𝘤𝘶𝘳𝘢𝘵𝘰 𝘯𝘦𝘨𝘭𝘪 𝘴𝘤𝘳𝘦𝘦𝘯𝘪𝘯𝘨 𝘥𝘪 𝘳𝘰𝘶𝘵𝘪𝘯𝘦. 𝘗𝘦𝘳 𝘴𝘢𝘱𝘦𝘳𝘯𝘦 𝘥𝘪 𝘱𝘪𝘶̀ 𝗖𝗼𝗻𝘁𝗮𝘁𝘁𝗮𝗰𝗶 𝗲 𝗽𝗿𝗲𝗻𝗱𝗶 𝘂𝗻 𝗮𝗽𝗽𝘂𝗻𝘁𝗮𝗺𝗲𝗻𝘁𝗼 06/4542 153𝘕𝘰𝘯 𝘴𝘰𝘭𝘰 𝘤𝘰𝘭𝘦𝘴𝘵𝘦𝘳𝘰𝘭𝘰 𝘣𝘶𝘰𝘯𝘰 𝘦 𝘤𝘢𝘵𝘵𝘪𝘷𝘰: 𝘭𝘢 𝘓𝘪𝘱𝘰𝘱𝘳𝘰𝘵𝘦𝘪𝘯𝘢 𝘈 𝘦̀ 𝘶𝘯 𝘷𝘢𝘭𝘰𝘳𝘦 𝘧𝘰𝘯𝘥𝘢𝘮𝘦𝘯𝘵𝘢𝘭𝘦 𝘲𝘶𝘢𝘯𝘵𝘪𝘧𝘪𝘤𝘢𝘳𝘦 𝘪𝘭 𝘳𝘪𝘴𝘤𝘩𝘪𝘰 𝘤𝘢𝘳𝘥𝘪𝘰𝘷𝘢𝘴𝘤𝘰𝘭𝘢𝘳𝘦. 𝘌𝘤𝘤𝘰 𝘥𝘪 𝘤𝘰𝘴𝘢 𝘴𝘪 𝘵𝘳𝘢𝘵𝘵𝘢 𝘦 𝘤𝘰𝘮𝘦 𝘮𝘰𝘯𝘪𝘵𝘰𝘳𝘢𝘳𝘭𝘢𝘊𝘰𝘭𝘦𝘴𝘵𝘦𝘳𝘰𝘭𝘰 𝘣𝘶𝘰𝘯𝘰 𝘦 𝘤𝘰𝘭𝘦𝘴𝘵𝘦𝘳𝘰𝘭𝘰 𝘤𝘢𝘵𝘵𝘪𝘷𝘰: 𝘥𝘶𝘦 𝘧𝘢𝘤𝘤𝘦 𝘥𝘦𝘭𝘭𝘢 𝘴𝘵𝘦𝘴𝘴𝘢 𝘮𝘦𝘥𝘢𝘨𝘭𝘪𝘢𝘓𝘢 𝘭𝘪𝘱𝘪𝘥𝘰𝘭𝘰𝘨𝘪𝘢 𝘮𝘰𝘥𝘦𝘳𝘯𝘢 𝘩𝘢 𝘵𝘳𝘢𝘥𝘪𝘻𝘪𝘰𝘯𝘢𝘭𝘮𝘦𝘯𝘵𝘦 𝘥𝘪𝘴𝘵𝘪𝘯𝘵𝘰 𝘪𝘭 𝘤𝘰𝘭𝘦𝘴𝘵𝘦𝘳𝘰𝘭𝘰 𝘪𝘯 “𝘣𝘶𝘰𝘯𝘰 𝘦 𝘤𝘢𝘵𝘵𝘪𝘷𝘰” 𝘪𝘯 𝘣𝘢𝘴𝘦 𝘢𝘭𝘭𝘢 𝘥𝘦𝘯𝘴𝘪𝘵𝘢̀ 𝘥𝘦𝘭𝘭𝘦 𝘭𝘪𝘱𝘰𝘱𝘳𝘰𝘵𝘦𝘪𝘯𝘦 𝘤𝘩𝘦 𝘭𝘰 𝘵𝘳𝘢𝘴𝘱𝘰𝘳𝘵𝘢𝘯𝘰. 𝘋𝘢𝘵𝘰 𝘤𝘩𝘦 𝘤𝘩𝘦 𝘯𝘰𝘯 𝘦𝘴𝘪𝘴𝘵𝘰𝘯𝘰 𝘷𝘢𝘭𝘰𝘳𝘪 𝘥𝘪 𝘴𝘪𝘤𝘶𝘳𝘦𝘻𝘻𝘢 𝘢𝘴𝘴𝘰𝘭𝘶𝘵𝘪 𝘦 𝘤𝘩𝘦 𝘪 𝘷𝘢𝘭𝘰𝘳𝘪 𝘭𝘪𝘮𝘪𝘵𝘦 𝘷𝘢𝘯𝘯𝘰 𝘤𝘰𝘯𝘵𝘦𝘴𝘵𝘶𝘢𝘭𝘪𝘻𝘻𝘢𝘵𝘪 𝘪𝘯 𝘣𝘢𝘴𝘦 𝘢𝘭 𝘱𝘳𝘰𝘧𝘪𝘭𝘰 𝘥𝘪 𝘳𝘪𝘴𝘤𝘩𝘪𝘰 𝘤𝘢𝘳𝘥𝘪𝘰𝘷𝘢𝘴𝘤𝘰𝘭𝘢𝘳𝘦 𝘥𝘦𝘭 𝘱𝘢𝘻𝘪𝘦𝘯𝘵𝘦, 𝘦̀ 𝘥𝘪 𝘤𝘰𝘮𝘶𝘯𝘦 𝘤𝘰𝘯𝘤𝘦𝘻𝘪𝘰𝘯𝘦 𝘭𝘢 𝘥𝘪𝘴𝘵𝘪𝘯𝘻𝘪𝘰𝘯𝘦 𝘵𝘳𝘢 𝘤𝘰𝘭𝘦𝘴𝘵𝘦𝘳𝘰𝘭𝘰 “𝘣𝘶𝘰𝘯𝘰 𝘦 𝘤𝘢𝘵𝘵𝘪𝘷𝘰”. 𝘐𝘯 𝘶𝘯𝘢 𝘧𝘢𝘮𝘰𝘴𝘢 𝘴𝘦𝘳𝘪𝘦 𝘵𝘦𝘭𝘦𝘷𝘪𝘴𝘪𝘷𝘢, 𝘢𝘭𝘭𝘢 𝘥𝘰𝘮𝘢𝘯𝘥𝘢 “𝘚𝘢𝘪 𝘲𝘶𝘢𝘭 𝘦̀ 𝘭𝘢 𝘥𝘪𝘧𝘧𝘦𝘳𝘦𝘯𝘻𝘢 𝘵𝘳𝘢 𝘪𝘭 𝘤𝘰𝘭𝘦𝘴𝘵𝘦𝘳𝘰𝘭𝘰 𝘣𝘶𝘰𝘯𝘰 𝘦 𝘲𝘶𝘦𝘭𝘭𝘰 𝘤𝘢𝘵𝘵𝘪𝘷𝘰”, 𝘭’𝘢𝘵𝘵𝘰𝘳𝘦 𝘥𝘪 𝘵𝘶𝘳𝘯𝘰 𝘳𝘪𝘴𝘱𝘰𝘯𝘥𝘦𝘷𝘢: “𝘕𝘰, 𝘮𝘢 𝘲𝘶𝘦𝘭𝘭𝘰 𝘤𝘢𝘵𝘵𝘪𝘷𝘰 𝘮𝘪 𝘴𝘦𝘮𝘣𝘳𝘢 𝘱𝘪𝘶̀ 𝘴𝘢𝘱𝘰𝘳𝘪𝘵𝘰”.𝘔𝘢 𝘲𝘶𝘢𝘭 𝘦̀ 𝘭𝘢 𝘥𝘪𝘧𝘧𝘦𝘳𝘦𝘯𝘻𝘢 𝘵𝘳𝘢 𝘪 𝘥𝘶𝘦? 𝘗𝘰𝘴𝘴𝘪𝘢𝘮𝘰 𝘥𝘪𝘳𝘦 𝘤𝘩𝘦 𝘪𝘭 𝘤𝘰𝘭𝘦𝘴𝘵𝘦𝘳𝘰𝘭𝘰 𝘤𝘢𝘵𝘵𝘪𝘷𝘰 𝘦̀ 𝘵𝘳𝘢𝘴𝘱𝘰𝘳𝘵𝘢𝘵𝘰 𝘥𝘢 𝘭𝘪𝘱𝘰𝘱𝘳𝘰𝘵𝘦𝘪𝘯𝘦 𝘢 𝘣𝘢𝘴𝘴𝘢 𝘥𝘦𝘯𝘴𝘪𝘵𝘢̀ (𝘓𝘋𝘓, 𝘭𝘰𝘸 𝘥𝘦𝘯𝘴𝘪𝘵𝘺 𝘭𝘪𝘱𝘰𝘱𝘳𝘰𝘵𝘦𝘪𝘯𝘴) 𝘦 𝘵𝘦𝘯𝘥𝘦 𝘢 𝘥𝘦𝘱𝘰𝘴𝘪𝘵𝘢𝘳𝘴𝘪 𝘯𝘦𝘪 𝘷𝘢𝘴𝘪 𝘴𝘢𝘯𝘨𝘶𝘪𝘨𝘯𝘪 𝘧𝘰𝘳𝘮𝘢𝘯𝘥𝘰 𝘭𝘦 𝘱𝘭𝘢𝘤𝘤𝘩𝘦 𝘢𝘵𝘦𝘳𝘰𝘴𝘤𝘭𝘦𝘳𝘰𝘵𝘪𝘤𝘩𝘦. 𝘈𝘭 𝘤𝘰𝘯𝘵𝘳𝘢𝘳𝘪𝘰 𝘪𝘭 𝘤𝘰𝘭𝘦𝘴𝘵𝘦𝘳𝘰𝘭𝘰 𝘣𝘶𝘰𝘯𝘰 𝘦̀ 𝘵𝘳𝘢𝘴𝘱𝘰𝘳𝘵𝘢𝘵𝘰 𝘥𝘢 𝘭𝘪𝘱𝘰𝘱𝘳𝘰𝘵𝘦𝘪𝘯𝘦 𝘢𝘥 𝘢𝘭𝘵𝘢 𝘥𝘦𝘯𝘴𝘪𝘵𝘢̀ (𝘏𝘋𝘓, 𝘩𝘪𝘨𝘩 𝘥𝘦𝘯𝘴𝘪𝘵𝘺 𝘭𝘪𝘱𝘰𝘱𝘳𝘰𝘵𝘦𝘪𝘯𝘴) 𝘦 𝘧𝘶𝘯𝘻𝘪𝘰𝘯𝘢 𝘥𝘢 “𝘴𝘤𝘢𝘷𝘦𝘯𝘨𝘦𝘳” (𝘥𝘢𝘭𝘭’𝘪𝘯𝘨𝘭𝘦𝘴𝘦 “𝘴𝘱𝘢𝘻𝘻𝘪𝘯𝘰”): 𝘳𝘪𝘮𝘶𝘰𝘷𝘦 𝘪𝘭 𝘤𝘰𝘭𝘦𝘴𝘵𝘦𝘳𝘰𝘭𝘰 𝘪𝘯 𝘦𝘤𝘤𝘦𝘴𝘴𝘰 𝘵𝘳𝘢𝘴𝘱𝘰𝘳𝘵𝘢𝘯𝘥𝘰𝘭𝘰 𝘥𝘢𝘭𝘭𝘢 𝘱𝘦𝘳𝘪𝘧𝘦𝘳𝘪𝘢 𝘢𝘭 𝘧𝘦𝘨𝘢𝘵𝘰.𝘐𝘭 𝘤𝘰𝘭𝘦𝘴𝘵𝘦𝘳𝘰𝘭𝘰 “𝘤𝘢𝘵𝘵𝘪𝘷𝘪𝘴𝘴𝘪𝘮𝘰”: 𝘭𝘢 𝘓𝘪𝘱𝘰𝘱𝘳𝘰𝘵𝘦𝘪𝘯𝘢 𝘈 𝘱𝘪𝘤𝘤𝘰𝘭𝘢𝘓𝘢 𝘤𝘪𝘯𝘦𝘮𝘢𝘵𝘰𝘨𝘳𝘢𝘧𝘪𝘢 𝘮𝘰𝘥𝘦𝘳𝘯𝘢 𝘤𝘪 𝘪𝘯𝘴𝘦𝘨𝘯𝘢 𝘤𝘩𝘦 𝘢𝘥 𝘶𝘯 𝘤𝘦𝘳𝘵𝘰 𝘱𝘶𝘯𝘵𝘰 𝘭𝘢 𝘥𝘪𝘢𝘭𝘦𝘵𝘵𝘪𝘤𝘢 𝘥𝘦𝘨𝘭𝘪 𝘰𝘱𝘱𝘰𝘴𝘵𝘪 𝘣𝘶𝘰𝘯𝘰/𝘤𝘢𝘵𝘵𝘪𝘷𝘰 𝘴𝘪 𝘤𝘰𝘮𝘱𝘭𝘪𝘤𝘢 𝘤𝘰𝘯 𝘭’𝘢𝘳𝘳𝘪𝘷𝘰 𝘥𝘦𝘭 “𝘤𝘢𝘵𝘵𝘪𝘷𝘪𝘴𝘴𝘪𝘮𝘰”. 𝘕𝘦𝘭 𝘯𝘰𝘴𝘵𝘳𝘰 𝘤𝘢𝘴𝘰 𝘴𝘪 𝘵𝘳𝘢𝘵𝘵𝘢 𝘥𝘪 𝘶𝘯𝘢 𝘧𝘳𝘢𝘻𝘪𝘰𝘯𝘦 𝘥𝘦𝘭 𝘤𝘰𝘭𝘦𝘴𝘵𝘦𝘳𝘰𝘭𝘰 𝘓𝘋𝘓, 𝘢𝘯𝘤𝘩𝘦 𝘥𝘦𝘵𝘵𝘢 “𝘵𝘦𝘳𝘻𝘰 𝘤𝘰𝘭𝘦𝘴𝘵𝘦𝘳𝘰𝘭𝘰” 𝘰 𝘓𝘪𝘱𝘰𝘱𝘳𝘰𝘵𝘦𝘪𝘯𝘢(𝘢) 𝘱𝘪𝘤𝘤𝘰𝘭𝘢.𝘘𝘶𝘦𝘴𝘵𝘰 𝘤𝘰𝘭𝘦𝘴𝘵𝘦𝘳𝘰𝘭𝘰 “𝘴𝘶𝘱𝘦𝘳 𝘤𝘢𝘵𝘵𝘪𝘷𝘰” 𝘶𝘯 𝘦̀ 𝘱𝘰’ 𝘯𝘢𝘴𝘤𝘰𝘴𝘵𝘰 𝘦 𝘵𝘳𝘢𝘴𝘤𝘶𝘳𝘢𝘵𝘰 𝘯𝘦𝘪 𝘤𝘰𝘮𝘶𝘯𝘪 𝘴𝘤𝘳𝘦𝘦𝘯𝘪𝘯𝘨 𝘥𝘪 𝘤𝘩𝘦𝘤𝘬-𝘶𝘱, 𝘴𝘱𝘦𝘴𝘴𝘰 𝘢𝘣𝘣𝘳𝘦𝘷𝘪𝘢𝘵𝘰 𝘤𝘰𝘮𝘦 𝘓𝘱(𝘢). 𝘔𝘢 𝘦̀ 𝘴𝘵𝘳𝘶𝘵𝘵𝘶𝘳𝘢𝘭𝘮𝘦𝘯𝘵𝘦 𝘢𝘴𝘴𝘪𝘮𝘪𝘭𝘢𝘣𝘪𝘭𝘦 𝘢𝘥 𝘶𝘯𝘢 𝘓𝘋𝘓 𝘮𝘢 𝘱𝘪𝘶̀ 𝘱𝘪𝘤𝘤𝘰𝘭𝘢 𝘦 “𝘢𝘱𝘱𝘪𝘤𝘤𝘪𝘤𝘰𝘴𝘢” 𝘰𝘷𝘷𝘦𝘳𝘰 𝘤𝘰𝘯 𝘶𝘯𝘢 𝘮𝘢𝘨𝘨𝘪𝘰𝘳 𝘵𝘦𝘯𝘥𝘦𝘯𝘻𝘢 𝘢 𝘥𝘦𝘱𝘰𝘴𝘪𝘵𝘢𝘳𝘴𝘪 𝘯𝘦𝘪 𝘷𝘢𝘴𝘪.𝘈 𝘥𝘪𝘧𝘧𝘦𝘳𝘦𝘯𝘻𝘢 𝘥𝘦𝘭𝘭𝘦 𝘓𝘋𝘓, 𝘪 𝘷𝘢𝘭𝘰𝘳𝘪 𝘥𝘪 𝘓𝘪𝘱𝘰𝘱𝘳𝘰𝘵𝘦𝘪𝘯𝘢 𝘈 𝘱𝘪𝘤𝘤𝘰𝘭𝘢 𝘴𝘰𝘯𝘰 𝘥𝘦𝘵𝘦𝘳𝘮𝘪𝘯𝘢𝘵𝘪 𝘨𝘦𝘯𝘦𝘵𝘪𝘤𝘢𝘮𝘦𝘯𝘵𝘦. 𝘚𝘰𝘯𝘰 𝘲𝘶𝘪𝘯𝘥𝘪 𝘱𝘰𝘤𝘰 𝘪𝘯𝘧𝘭𝘶𝘦𝘯𝘻𝘢𝘵𝘪 𝘥𝘢𝘭𝘭𝘢 𝘥𝘪𝘦𝘵𝘢 𝘦 𝘮𝘦𝘯𝘰 𝘤𝘰𝘯𝘵𝘳𝘰𝘭𝘭𝘢𝘣𝘪𝘭𝘪 𝘤𝘰𝘯 𝘭𝘦 𝘤𝘭𝘢𝘴𝘴𝘪𝘤𝘩𝘦 𝘮𝘪𝘴𝘶𝘳𝘦 𝘧𝘢𝘳𝘮𝘢𝘤𝘰𝘭𝘰𝘨𝘪𝘤𝘩𝘦 𝘤𝘰𝘮𝘦 𝘭𝘦 𝘴𝘵𝘢𝘵𝘪𝘯𝘦. 𝘓𝘢 𝘱𝘳𝘰𝘣𝘢𝘣𝘪𝘭𝘪𝘵𝘢̀ 𝘥𝘪 𝘦𝘷𝘦𝘯𝘵𝘪 𝘤𝘢𝘳𝘥𝘪𝘰𝘷𝘢𝘴𝘤𝘰𝘭𝘢𝘳𝘪 𝘢𝘶𝘮𝘦𝘯𝘵𝘢 𝘭𝘪𝘯𝘦𝘢𝘳𝘮𝘦𝘯𝘵𝘦 𝘢𝘭𝘭’𝘢𝘶𝘮𝘦𝘯𝘵𝘢𝘳𝘦 𝘥𝘦𝘭𝘭𝘢 𝘤𝘰𝘯𝘤𝘦𝘯𝘵𝘳𝘢𝘻𝘪𝘰𝘯𝘦 𝘦𝘮𝘢𝘵𝘪𝘤𝘢 𝘥𝘦𝘭𝘭𝘢 𝘓𝘱(𝘢), 𝘴𝘱𝘦𝘤𝘪𝘢𝘭𝘮𝘦𝘯𝘵𝘦 𝘢 𝘤𝘰𝘯𝘤𝘦𝘯𝘵𝘳𝘢𝘻𝘪𝘰𝘯𝘪 > 50 𝘮𝘨/𝘥𝘭. 𝘓𝘢 𝘱𝘦𝘤𝘶𝘭𝘪𝘢𝘳𝘪𝘵𝘢̀ 𝘥𝘦𝘭𝘭𝘢 𝘭𝘪𝘱𝘰𝘱𝘳𝘰𝘵𝘦𝘪𝘯𝘢 𝘈, 𝘢 𝘥𝘪𝘧𝘧𝘦𝘳𝘦𝘯𝘻𝘦 𝘥𝘦𝘭𝘭𝘦 𝘢𝘭𝘵𝘳𝘦 𝘭𝘪𝘱𝘰𝘱𝘳𝘰𝘵𝘦𝘪𝘯𝘦, 𝘦̀ 𝘲𝘶𝘦𝘭𝘭𝘢 𝘥𝘪 𝘢𝘴𝘴𝘰𝘤𝘪𝘢𝘳𝘴𝘪 𝘮𝘢𝘨𝘨𝘪𝘰𝘳𝘮𝘦𝘯𝘵𝘦 𝘢𝘨𝘭𝘪 𝘦𝘷𝘦𝘯𝘵𝘪 𝘵𝘳𝘰𝘮𝘣𝘰𝘵𝘪𝘤𝘪 𝘦 𝘢𝘭𝘭𝘦 𝘤𝘢𝘭𝘤𝘪𝘧𝘪𝘤𝘢𝘻𝘪𝘰𝘯𝘪 𝘤𝘢𝘳𝘥𝘪𝘰𝘷𝘢𝘴𝘤𝘰𝘭𝘢𝘳𝘪.𝘐𝘯𝘵𝘦𝘳𝘤𝘦𝘵𝘵𝘢𝘳𝘦 𝘪𝘭 “𝘴𝘶𝘱𝘦𝘳 𝘤𝘢𝘵𝘵𝘪𝘷𝘰”: 𝘤𝘰𝘮𝘦 𝘧𝘶𝘯𝘻𝘪𝘰𝘯𝘢 𝘭𝘢 𝘓𝘪𝘱𝘰𝘱𝘳𝘰𝘵𝘦𝘪𝘯𝘢 𝘈?𝘚𝘦𝘤𝘰𝘯𝘥𝘰 𝘭𝘦 𝘶𝘭𝘵𝘪𝘮𝘦 𝘭𝘪𝘯𝘦𝘦 𝘨𝘶𝘪𝘥𝘢 𝘦𝘶𝘳𝘰𝘱𝘦𝘦, 𝘭𝘢 𝘤𝘰𝘯𝘤𝘦𝘯𝘵𝘳𝘢𝘻𝘪𝘰𝘯𝘦 𝘦𝘮𝘢𝘵𝘪𝘤𝘢 𝘥𝘪 𝘓𝘱(𝘢) 𝘥𝘰𝘷𝘳𝘦𝘣𝘣𝘦 𝘦𝘴𝘴𝘦𝘳𝘦 𝘵𝘦𝘴𝘵𝘢𝘵𝘢 𝘢𝘭𝘮𝘦𝘯𝘰 𝘶𝘯𝘢 𝘷𝘰𝘭𝘵𝘢 𝘯𝘦𝘭𝘭𝘢 𝘷𝘪𝘵𝘢. 𝘚𝘪 𝘦𝘴𝘦𝘨𝘶𝘦 𝘷𝘦𝘭𝘰𝘤𝘦𝘮𝘦𝘯𝘵𝘦 𝘢 𝘶𝘯 𝘤𝘰𝘴𝘵𝘰 𝘮𝘰𝘭𝘵𝘰 𝘤𝘰𝘯𝘵𝘦𝘯𝘶𝘵𝘰, 𝘮𝘢 𝘤𝘰𝘯𝘴𝘦𝘯𝘵𝘦 𝘥𝘪 𝘴𝘵𝘳𝘢𝘵𝘪𝘧𝘪𝘤𝘢𝘳𝘦 𝘮𝘦𝘨𝘭𝘪𝘰 𝘪𝘭 𝘳𝘪𝘴𝘤𝘩𝘪𝘰 𝘤𝘢𝘳𝘥𝘪𝘰𝘷𝘢𝘴𝘤𝘰𝘭𝘢𝘳𝘦 𝘪𝘯𝘥𝘪𝘷𝘪𝘥𝘶𝘢𝘭𝘦. 𝘜𝘯𝘰 𝘴𝘤𝘳𝘦𝘦𝘯𝘪𝘯𝘨 𝘱𝘪𝘶̀ 𝘢𝘱𝘱𝘳𝘰𝘧𝘰𝘯𝘥𝘪𝘵𝘰 𝘢𝘯𝘥𝘳𝘦𝘣𝘣𝘦 𝘴𝘰𝘮𝘮𝘪𝘯𝘪𝘴𝘵𝘳𝘢𝘵𝘰 𝘢 𝘤𝘰𝘭𝘰𝘳𝘰 𝘤𝘩𝘦 𝘩𝘢𝘯𝘯𝘰 𝘴𝘰𝘧𝘧𝘦𝘳𝘵𝘰 𝘥𝘪 𝘦𝘷𝘦𝘯𝘵𝘪 𝘤𝘢𝘳𝘥𝘪𝘰𝘷𝘢𝘴𝘤𝘰𝘭𝘢𝘳𝘪 𝘱𝘳𝘦𝘤𝘰𝘤𝘪 (< 55 𝘢𝘯𝘯𝘪 𝘱𝘦𝘳 𝘪 𝘮𝘢𝘴𝘤𝘩𝘪, < 65 𝘢𝘯𝘯𝘪 𝘱𝘦𝘳 𝘭𝘦 𝘧𝘦𝘮𝘮𝘪𝘯𝘦) 𝘦 𝘢𝘪 𝘭𝘰𝘳𝘰 𝘱𝘢𝘳𝘦𝘯𝘵𝘪 𝘥𝘪 𝘱𝘳𝘪𝘮𝘰 𝘨𝘳𝘢𝘥𝘰 𝘦 𝘢𝘪 𝘴𝘰𝘨𝘨𝘦𝘵𝘵𝘪 𝘢𝘧𝘧𝘦𝘵𝘵𝘪 𝘥𝘢 𝘪𝘱𝘦𝘳𝘤𝘰𝘭𝘦𝘴𝘵𝘦𝘳𝘰𝘭𝘦𝘮𝘪𝘢 𝘴𝘦𝘷𝘦𝘳𝘢.𝘓𝘢 𝘭𝘪𝘱𝘰𝘱𝘳𝘰𝘵𝘦𝘪𝘯𝘢 𝘈 𝘤𝘰𝘯𝘴𝘦𝘯𝘵𝘦 𝘶𝘯𝘢 𝘳𝘢𝘱𝘪𝘥𝘢 𝘴𝘵𝘳𝘢𝘵𝘪𝘧𝘪𝘤𝘢𝘻𝘪𝘰𝘯𝘦 𝘥𝘦𝘭 𝘳𝘪𝘴𝘤𝘩𝘪𝘰 𝘤𝘢𝘳𝘥𝘪𝘰𝘷𝘢𝘴𝘤𝘰𝘭𝘢𝘳𝘦 𝘥𝘦𝘭 𝘱𝘢𝘻𝘪𝘦𝘯𝘵𝘦 𝘦𝘥 𝘦̀ 𝘱𝘰𝘤𝘰 𝘪𝘯𝘧𝘭𝘶𝘦𝘯𝘻𝘢𝘵𝘢 𝘥𝘢𝘭𝘭𝘢 𝘥𝘪𝘦𝘵𝘢. 𝘗𝘦𝘳𝘮𝘦𝘵𝘵𝘦 𝘲𝘶𝘪𝘯𝘥𝘪 𝘥𝘪 𝘪𝘯𝘥𝘪𝘷𝘪𝘥𝘶𝘢𝘳𝘦 𝘱𝘳𝘦𝘤𝘰𝘤𝘦𝘮𝘦𝘯𝘵𝘦 𝘲𝘶𝘦𝘪 𝘱𝘢𝘻𝘪𝘦𝘯𝘵𝘪 𝘤𝘩𝘦 𝘱𝘰𝘴𝘴𝘰𝘯𝘰 𝘣𝘦𝘯𝘦𝘧𝘪𝘤𝘪𝘢𝘳𝘦 𝘥𝘪 𝘶𝘯 𝘵𝘳𝘢𝘵𝘵𝘢𝘮𝘦𝘯𝘵𝘰 (𝘦 𝘱𝘦𝘳 𝘭𝘦 𝘥𝘪𝘴𝘭𝘪𝘱𝘪𝘥𝘦𝘮𝘪𝘦 𝘤’𝘦̀ 𝘴𝘰𝘭𝘰 𝘭’𝘪𝘮𝘣𝘢𝘳𝘢𝘻𝘻𝘰 𝘥𝘦𝘭𝘭𝘢 𝘴𝘤𝘦𝘭𝘵𝘢: 𝘥𝘢𝘨𝘭𝘪 𝘪𝘯𝘵𝘦𝘨𝘳𝘢𝘵𝘰𝘳𝘪 𝘢𝘪 𝘧𝘢𝘳𝘮𝘢𝘤𝘪 𝘥𝘪 𝘶𝘭𝘵𝘪𝘮𝘪𝘴𝘴𝘪𝘮𝘢 𝘨𝘦𝘯𝘦𝘳𝘢𝘻𝘪𝘰𝘯𝘦). 𝘖𝘱𝘱𝘶𝘳𝘦 𝘪 𝘱𝘢𝘻𝘪𝘦𝘯𝘵𝘪 𝘢 𝘤𝘶𝘪 𝘥𝘦𝘴𝘵𝘪𝘯𝘢𝘳𝘦 𝘮𝘦𝘵𝘰𝘥𝘪𝘤𝘩𝘦 𝘥𝘪 𝘪𝘮𝘢𝘨𝘪𝘯𝘨 𝘱𝘦𝘳 𝘷𝘦𝘥𝘦𝘳𝘦 𝘭𝘢 𝘱𝘳𝘦𝘴𝘦𝘯𝘻𝘢 𝘥𝘪 𝘱𝘭𝘢𝘤𝘤𝘩𝘦 𝘤𝘰𝘮𝘦 𝘪𝘭 𝘥𝘰𝘱𝘱𝘭𝘦𝘳 𝘥𝘦𝘪 𝘵𝘳𝘰𝘯𝘤𝘩𝘪 𝘴𝘰𝘷𝘳𝘢-𝘢𝘰𝘳𝘵𝘪𝘤𝘪 𝘰 𝘭𝘢 𝘵𝘢𝘤 𝘤𝘰𝘳𝘰𝘯𝘢𝘳𝘪𝘤𝘢.𝘓𝘪𝘱𝘰𝘱𝘳𝘰𝘵𝘦𝘪𝘯𝘢 𝘈: 𝘶𝘯’𝘢𝘭𝘭𝘦𝘢𝘵𝘢 𝘱𝘦𝘳 𝘭𝘢 𝘱𝘳𝘦𝘷𝘦𝘯𝘻𝘪𝘰𝘯𝘦𝘓’𝘢𝘴𝘴𝘪𝘰𝘮𝘢 𝘴𝘵𝘰𝘳𝘪𝘤𝘰 𝘥𝘦𝘭𝘭𝘢 𝘭𝘪𝘱𝘪𝘥𝘰𝘭𝘰𝘨𝘪𝘢 𝘮𝘰𝘥𝘦𝘳𝘯𝘢 “𝘵𝘩𝘦 𝘭𝘰𝘸𝘦𝘳 𝘵𝘩𝘦 𝘣𝘦𝘵𝘵𝘦𝘳” (𝘲𝘶𝘢𝘯𝘵𝘰 𝘱𝘪𝘶̀ 𝘦̀ 𝘣𝘢𝘴𝘴𝘰 𝘪𝘭 𝘤𝘰𝘭𝘦𝘴𝘵𝘦𝘳𝘰𝘭𝘰 𝘮𝘦𝘨𝘭𝘪𝘰 𝘦̀ 𝘱𝘦𝘳 𝘪𝘭 𝘱𝘢𝘻𝘪𝘦𝘯𝘵𝘦) 𝘦̀ 𝘴𝘵𝘢𝘵𝘰 𝘴𝘰𝘴𝘵𝘪𝘵𝘶𝘪𝘵𝘰 𝘥𝘢 “𝘵𝘩𝘦 𝘦𝘢𝘳𝘭𝘪𝘦𝘳 𝘵𝘩𝘦 𝘣𝘦𝘵𝘵𝘦𝘳” (𝘱𝘳𝘪𝘮𝘢 𝘴𝘪 𝘢𝘣𝘣𝘢𝘴𝘴𝘢 𝘪𝘭 𝘤𝘰𝘭𝘦𝘴𝘵𝘦𝘳𝘰𝘭𝘰 𝘵𝘢𝘯𝘵𝘰 𝘮𝘦𝘨𝘭𝘪𝘰 𝘦̀ 𝘪𝘯 𝘵𝘦𝘳𝘮𝘪𝘯𝘪 𝘥𝘪 𝘱𝘳𝘦𝘷𝘦𝘯𝘻𝘪𝘰𝘯𝘦).𝘐𝘯 𝘲𝘶𝘦𝘴𝘵’𝘰𝘵𝘵𝘪𝘤𝘢, 𝘭𝘢 𝘭𝘪𝘱𝘰𝘱𝘳𝘰𝘵𝘦𝘪𝘯𝘢 𝘈 𝘤𝘪 𝘱𝘦𝘳𝘮𝘦𝘵𝘵𝘦 𝘥𝘪 𝘪𝘯𝘥𝘪𝘷𝘪𝘥𝘶𝘢𝘳𝘦 𝘱𝘳𝘦𝘤𝘰𝘤𝘦𝘮𝘦𝘯𝘵𝘦 𝘲𝘶𝘦𝘪 𝘱𝘢𝘻𝘪𝘦𝘯𝘵𝘪 𝘤𝘩𝘦 𝘱𝘰𝘴𝘴𝘰𝘯𝘰 𝘣𝘦𝘯𝘦𝘧𝘪𝘤𝘪𝘢𝘳𝘦 𝘱𝘳𝘪𝘮𝘢 𝘦 𝘱𝘪𝘶̀ 𝘢 𝘭𝘶𝘯𝘨𝘰 𝘥𝘪 𝘶𝘯 𝘵𝘳𝘢𝘵𝘵𝘢𝘮𝘦𝘯𝘵𝘰 (𝘯𝘰𝘯 𝘯𝘦𝘤𝘦𝘴𝘴𝘢𝘳𝘪𝘢𝘮𝘦𝘯𝘵𝘦 𝘴𝘰𝘭𝘰 𝘧𝘢𝘳𝘮𝘢𝘤𝘰𝘭𝘰𝘨𝘪𝘤𝘰), 𝘱𝘳𝘦𝘷𝘦𝘯𝘦𝘯𝘥𝘰 𝘭𝘢 𝘧𝘰𝘳𝘮𝘢𝘻𝘪𝘰𝘯𝘦 𝘰 𝘭𝘢 𝘱𝘳𝘰𝘨𝘳𝘦𝘴𝘴𝘪𝘰𝘯𝘦 𝘥𝘦𝘭𝘭𝘢 𝘱𝘭𝘢𝘤𝘤𝘢. 𝘘𝘶𝘪𝘯𝘥𝘪, 𝘳𝘪𝘥𝘶𝘤𝘦𝘯𝘥𝘰 𝘨𝘭𝘪 𝘦𝘷𝘦𝘯𝘵𝘪 𝘤𝘢𝘳𝘥𝘪𝘰𝘷𝘢𝘴𝘤𝘰𝘭𝘢𝘳𝘪. 𝘓𝘢 𝘓𝘪𝘱𝘰𝘱𝘳𝘰𝘵𝘦𝘪𝘯𝘢 𝘈 𝘳𝘢𝘱𝘱𝘳𝘦𝘴𝘦𝘯𝘵𝘢 𝘶𝘯 𝘮𝘢𝘳𝘬𝘦𝘳 𝘪𝘮𝘱𝘰𝘳𝘵𝘢𝘯𝘵𝘦 𝘱𝘦𝘳 𝘤𝘢𝘱𝘪𝘳𝘦 𝘢 𝘲𝘶𝘢𝘭𝘦 𝘱𝘢𝘻𝘪𝘦𝘯𝘵𝘦 𝘥𝘦𝘴𝘵𝘪𝘯𝘢𝘳𝘦 𝘶𝘯’𝘦𝘷𝘦𝘯𝘵𝘶𝘢𝘭𝘦 𝘵𝘦𝘳𝘢𝘱𝘪𝘢 𝘪𝘱𝘰𝘭𝘪𝘱𝘪𝘥𝘦𝘮𝘪𝘻𝘻𝘢𝘯𝘵𝘦 (𝘶𝘵𝘪𝘭𝘦 𝘱𝘦𝘳 𝘢𝘣𝘣𝘢𝘴𝘴𝘢𝘳𝘦 𝘪 𝘭𝘪𝘷𝘦𝘭𝘭𝘰 𝘥𝘪 𝘤𝘰𝘭𝘦𝘴𝘵𝘦𝘳𝘰𝘭𝘰). 𝘐𝘯 𝘵𝘦𝘳𝘮𝘪𝘯𝘪 𝘥𝘪 𝘱𝘳𝘦𝘷𝘦𝘯𝘻𝘪𝘰𝘯𝘦, 𝘵𝘶𝘵𝘵𝘢𝘷𝘪𝘢, 𝘶𝘯𝘢 𝘥𝘪𝘦𝘵𝘢 𝘴𝘢𝘯𝘢 𝘦𝘥 𝘦𝘲𝘶𝘪𝘭𝘪𝘣𝘳𝘢𝘵𝘢, 𝘱𝘰𝘷𝘦𝘳𝘢 𝘥𝘪 𝘨𝘳𝘢𝘴𝘴𝘪, 𝘢𝘵𝘵𝘪𝘷𝘪𝘵𝘢̀ 𝘧𝘪𝘴𝘪𝘤𝘢 𝘳𝘦𝘨𝘰𝘭𝘢𝘳𝘦 𝘦 𝘤𝘰𝘳𝘳𝘦𝘵𝘵𝘦 𝘢𝘣𝘪𝘵𝘶𝘥𝘪𝘯𝘪 𝘲𝘶𝘰𝘵𝘪𝘥𝘪𝘢𝘯𝘦 𝘳𝘦𝘴𝘵𝘢𝘯𝘰 𝘪𝘮𝘱𝘳𝘦𝘴𝘤𝘪𝘯𝘥𝘪𝘣𝘪𝘭𝘪.- 𝗗𝗮𝗹 𝗹𝘂𝗻𝗲𝗱𝗶̀ 𝗮𝗹 𝘃𝗲𝗻𝗲𝗿𝗱𝗶̀ 𝟬𝟵.𝟬𝟬 – 𝟭𝟵,𝟬𝟬 – 𝘀𝗮𝗯𝗮𝘁𝗼 𝟬𝟵,𝟬𝟬 – 𝟭𝟯,𝟬𝟬 – 𝟬𝟲/𝟰𝟱𝟰𝟮 𝟭𝟱𝟯𝟮